Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-082294
Filing Date
2014-03-04
Accepted
2014-03-04 16:17:42
Documents
16
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d642244d10k.htm 10-K 1286121
2 EX-10.16 d642244dex1016.htm EX-10.16 28465
3 EX-10.29 d642244dex1029.htm EX-10.29 185351
4 EX-21.1 d642244dex211.htm EX-21.1 2323
5 EX-23.1 d642244dex231.htm EX-23.1 1296
6 EX-31.1 d642244dex311.htm EX-31.1 6358
7 EX-31.2 d642244dex312.htm EX-31.2 6367
8 EX-32.1 d642244dex321.htm EX-32.1 3103
9 EX-32.2 d642244dex322.htm EX-32.2 3112
16 GRAPHIC g642244g49k41.jpg GRAPHIC 45955
  Complete submission text file 0001193125-14-082294.txt   8787663

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT mack-20131231.xml EX-101.INS 1044669
11 XBRL TAXONOMY EXTENSION SCHEMA mack-20131231.xsd EX-101.SCH 95076
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mack-20131231_cal.xml EX-101.CAL 95373
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mack-20131231_def.xml EX-101.DEF 303159
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20131231_lab.xml EX-101.LAB 705552
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20131231_pre.xml EX-101.PRE 501452
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35409 | Film No.: 14664914
SIC: 2834 Pharmaceutical Preparations